Activated mouse CD4+Foxp3- T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity

The regulatory activities of mouse CD4+Foxp3+ T cells on various immune cells, including NK ceils, have been well documented. Under some conditions, conventional CD4+Foxp3- T cells in the periphery are able to acquire inhibi- tory function on other T cells, but their roles in controlling innate immu...

Full description

Saved in:
Bibliographic Details
Published inCell research Vol. 22; no. 12; pp. 1696 - 1706
Main Authors Wang, Xiaojuan, Cui, Yanyan, Luo, Gaoxing, Wang, Qinghong, Hu, Jie, He, Weifeng, Yuan, Jun, Zhou, Junyi, Wu, Yan, Sun, Xiaofeng, Robson, Simon C, Li, Xianchang, Tan, Jiangling, Peng, Yanmeng, Xue, Gang, Lu, Linrong, Gao, Wenda, Wu, Jun
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2012
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The regulatory activities of mouse CD4+Foxp3+ T cells on various immune cells, including NK ceils, have been well documented. Under some conditions, conventional CD4+Foxp3- T cells in the periphery are able to acquire inhibi- tory function on other T cells, but their roles in controlling innate immune cells are poorly defined. As a potential cellular therapy for cancer, ex vivo activated CD4+Foxp3- effector T cells are often infused back in vivo to suppress tumor growth and metastasis. Whether such activated T cells could affect NK-cell control of tumorigenesis is unclear. In the present study, we found that mitogen-activated CD4~Foxp3- T cells exhibited potent suppressor function on NK-cell proliferation and cytotoxicity in vitro, and notably facilitated B16 melanoma metastasis in vivo. Suppression of NK cells by activated CD4+Foxp3- T cells is cell-cell contact dependent and is mediated by Qa-I:NKG2A interac- tion, as administration of antibodies blocking either Qa-1 or NKG2A could completely reverse this suppression, and significantly inhibited otherwise facilitated melanoma metastasis. Moreover, activated CD4+Foxp3- cells from Qa-1 knockout mice completely lost the suppressor activity on NK cells, and failed to facilitate melanoma metastasis when transferred in vivo. Taken together, our findings indicate that innate anti-tumor response is counter regulated by the activation of adaptive immunity, a phenomenon we term as "activation-induced inhibition". Thus, the regulatory role of activated CD4+Foxp3- T cells in NK-cell activity must be taken into consideration in the future design of cancer therapies.
Bibliography:31-1568/Q
NK cells; T cells; suppression; melanoma; metastasis; Qa-1
The regulatory activities of mouse CD4+Foxp3+ T cells on various immune cells, including NK ceils, have been well documented. Under some conditions, conventional CD4+Foxp3- T cells in the periphery are able to acquire inhibi- tory function on other T cells, but their roles in controlling innate immune cells are poorly defined. As a potential cellular therapy for cancer, ex vivo activated CD4+Foxp3- effector T cells are often infused back in vivo to suppress tumor growth and metastasis. Whether such activated T cells could affect NK-cell control of tumorigenesis is unclear. In the present study, we found that mitogen-activated CD4~Foxp3- T cells exhibited potent suppressor function on NK-cell proliferation and cytotoxicity in vitro, and notably facilitated B16 melanoma metastasis in vivo. Suppression of NK cells by activated CD4+Foxp3- T cells is cell-cell contact dependent and is mediated by Qa-I:NKG2A interac- tion, as administration of antibodies blocking either Qa-1 or NKG2A could completely reverse this suppression, and significantly inhibited otherwise facilitated melanoma metastasis. Moreover, activated CD4+Foxp3- cells from Qa-1 knockout mice completely lost the suppressor activity on NK cells, and failed to facilitate melanoma metastasis when transferred in vivo. Taken together, our findings indicate that innate anti-tumor response is counter regulated by the activation of adaptive immunity, a phenomenon we term as "activation-induced inhibition". Thus, the regulatory role of activated CD4+Foxp3- T cells in NK-cell activity must be taken into consideration in the future design of cancer therapies.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These four authors contributed equally to this work.
ISSN:1001-0602
1748-7838
DOI:10.1038/cr.2012.128